002788 鹭燕医药
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.81112.83013.24312.55412.780
总资产报酬率 ROA (%)0.7043.0843.1703.2953.350
投入资产回报率 ROIC (%)0.9124.0514.1544.3414.138

边际利润分析
销售毛利率 (%)7.3637.6047.7857.8157.960
营业利润率 (%)2.0552.3612.3942.3132.406
息税前利润/营业总收入 (%)3.0823.4893.5253.4573.490
净利润/营业总收入 (%)1.6261.8371.8031.7361.718

收益指标分析
经营活动净收益/利润总额(%)114.018103.549110.971105.120107.437
价值变动净收益/利润总额(%)-3.365-2.590-1.485-0.514-0.539
营业外收支净额/利润总额(%)0.0180.1840.0142.248-0.703

偿债能力分析
流动比率 (X)1.1591.1611.1741.1861.220
速动比率 (X)0.8500.8400.8670.8620.876
资产负债率 (%)74.68474.75876.31874.38071.446
带息债务/全部投入资本 (%)65.28364.99067.05465.077--
股东权益/带息债务 (%)49.38550.25745.45349.79060.756
股东权益/负债合计 (%)33.58533.41730.25433.52438.888
利息保障倍数 (X)3.0013.1063.1183.1703.171

营运能力分析
应收账款周转天数 (天)100.799104.071100.80592.1550.000
存货周转天数 (天)48.26350.28748.37747.8890.000